Latosha Mollette
Family · Jonesboro, LANPI 1821641374
Payments from drug & device makers
Across 210 payments — averaging $17.52 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$618
- GSK$547
- AbbVie$480
- Novo Nordisk$251
- Lilly USA, LLC$250
- Merck$215
- plus $1K from 25 others
What the payments were for
- Food & beverage$3,679100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 25 | $618 |
| GSK | 33 | $547 |
| AbbVie | 42 | $480 |
| Novo Nordisk | 16 | $251 |
| Lilly USA, LLC | 15 | $250 |
| Merck | 13 | $215 |
| Biohaven Pharmaceuticals, Inc. | 1 | $125 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $114 |
| Amgen | 6 | $107 |
| Sumitomo Pharma America, Inc. | 5 | $105 |
| Advanced Respiratory, Inc | 3 | $96 |
| Otsuka America Pharmaceutical, Inc. | 5 | $86 |
| Avanir Pharmaceuticals, Inc. | 4 | $72 |
| Biohaven Pharmaceutical Holding Company Ltd. | 3 | $67 |
| Bayer | 4 | $63 |
| Astellas Pharma US Inc | 4 | $55 |
| Pfizer | 3 | $52 |
| Teva Pharmaceuticals USA, Inc. | 4 | $51 |
| Verona Pharma, Inc. | 2 | $43 |
| Biodelivery Sciences International, Inc. | 3 | $40 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $36 |
| Eisai Inc. | 2 | $32 |
| Philips North America LLC | 2 | $30 |
| Novartis | 1 | $23 |
| Johnson & Johnson | 1 | $22 |
| IBSA Pharma Inc. | 1 | $18 |
| Amarin Pharma, Inc. | 1 | $18 |
| Exact Sciences | 1 | $17 |
| Axsome Therapeutics, Inc. | 1 | $17 |
| Smith+Nephew | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NURTEC ODT$125
- BREZTRI$125
How this compares
$3,679 in reported general payments places this provider in the 85th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 63 | $66,038 |
| OzempicSemaglutide | 62 | $60,637 |
| FarxigaDapagliflozin Propanediol | 66 | $57,875 |
| EliquisApixaban | 31 | $30,933 |
| LinzessLinaclotide | 34 | $28,688 |
| EntrestoSacubitril/Valsartan | 18 | $22,717 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $21,289 |
| Bydureon BciseExenatide Microspheres | 18 | $19,935 |
| TrulicityDulaglutide | 15 | $16,013 |
| JardianceEmpagliflozin | 12 | $15,702 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 17 | $10,661 |
| Spiriva HandihalerTiotropium Bromide | 13 | $6,546 |
| SymbicortBudesonide/Formoterol Fumarate | 20 | $4,612 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 75 | $1,768 |
| Nifedipine ErNifedipine | 55 | $960 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $250 | $82,05178 claims |
| AstraZenecaFarxiga, Breztri Aerosphere, Symbicort | $618 | $73,148103 claims |
| Novo NordiskOzempic | $251 | $60,63762 claims |
| PfizerEliquis | $52 | $30,93331 claims |
| AbbVieLinzess | $480 | $28,68834 claims |
| NovartisEntresto | $23 | $22,71718 claims |
| GSKTrelegy Ellipta | $547 | $21,28925 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 3,610 family providers in Louisiana.
Other family in Jonesboro
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.